Stay ahead of developments in federal and state health care law, regulation and transactions with timely, expert news and analysis.
The health-care industry is applauding signals of greater cooperation between Congress and the Medicare agency in tackling burdensome regulations.
“It can be very beneficial for an agency to have lawmakers engage with them,” Dan Mendelson, president of Avalere Health, a health-care consulting company in Washington, told Bloomberg BNA Oct. 12. “If Congress demands or asks the agency to do something, and they’re both in agreement, it can be very useful in speeding up the process, including for deregulation.”
Mendelson’s comments are in relation to a letter from the chairman of a key Senate committee that praised the Centers for Medicare & Medicaid Services for requesting feedback from patients and health-care providers on ways to increase quality of patient care while reducing regulatory burden, and asked for specific ways Congress can assist the agency. The Department of Health and Human Services, the parent agency of CMS, has authority over regulatory issues, while Congress can make statutory changes.“I am committed to helping you achieve these goals of maintaining flexibility and efficiency throughout the Medicare program,” Sen. Orrin Hatch (R-Utah) wrote Oct. 6 to CMS Administrator Seema Verma. “Realizing that CMS is likely to receive recommendations for actions that are beyond the agency’s statutory authority, I am especially interested in promising [request for information] recommendations that require Congressional action.” The agency’s request for feedback is part of a “request for information” contained in several recent Medicare payment proposals, Hatch noted.
Lindsay Bealor Greenleaf, director at ADVI, a reimbursement and policy consulting firm that advises clients in the pharmaceutical industry, said the letter is a sign of good things to come for the industry.
“It was very encouraging to see CMS request stakeholder feedback in its proposed rules on how to streamline reporting requirements and reduce regulatory burdens in general,” she told Bloomberg BNA Oct. 12. “Hatch’s subsequent letter to CMS asking for ideas on how Congress could help in this effort is a promising sign that this administration and Congress will follow through on their promises to reduce regulatory burdens for providers.”
While industry sees promise, an advocacy group for Medicare patients urged caution in making program changes. David A. Lipschutz, senior policy attorney for the Center for Medicare Advocacy, warned Congress and the CMS to proceed with caution when it comes to deregulation.
“Look before you leap. Do not start trying to reduce regulations for the sake of reducing regulations, there can be unintended consequences,” he said. “There are some important consumer protections that providers might see as burdensome, like paperwork requirements and notices, but ensuring that consumers are adequately protected is of the utmost importance.”
Hatch, in his letter, emphasized that a “thorough review of regulations” in conjunction with health-care providers will properly identify requirements that are outdated, unneeded, or contrary to high-quality and efficient care.
Another congressional committee, House Ways and Means, has launched its own effort to cut Medicare red tape. During the summer, health-care groups such as the American Hospital Association responded favorably to the panel’s effort, calling for Congress to scale back regulations they say burden hospitals and providers. Examples of requested relief include making bundled payment demonstrations voluntary, revising penalties for hospitals that have to readmit patients, and fashioning coverage changes for telehealth services.
To contact the reporter on this story: Mike Stankiewicz in Washington at firstname.lastname@example.org
To contact the editor responsible for this story: Brian Broderick at email@example.com
The letter is at http://src.bna.com/ti7
Copyright © 2017 The Bureau of National Affairs, Inc. All Rights Reserved.
All Bloomberg BNA treatises are available on standing order, which ensures you will always receive the most current edition of the book or supplement of the title you have ordered from Bloomberg BNA’s book division. As soon as a new supplement or edition is published (usually annually) for a title you’ve previously purchased and requested to be placed on standing order, we’ll ship it to you to review for 30 days without any obligation. During this period, you can either (a) honor the invoice and receive a 5% discount (in addition to any other discounts you may qualify for) off the then-current price of the update, plus shipping and handling or (b) return the book(s), in which case, your invoice will be cancelled upon receipt of the book(s). Call us for a prepaid UPS label for your return. It’s as simple and easy as that. Most importantly, standing orders mean you will never have to worry about the timeliness of the information you’re relying on. And, you may discontinue standing orders at any time by contacting us at 1.800.960.1220 or by sending an email to firstname.lastname@example.org.
Put me on standing order at a 5% discount off list price of all future updates, in addition to any other discounts I may quality for. (Returnable within 30 days.)
Notify me when updates are available (No standing order will be created).
This Bloomberg BNA report is available on standing order, which ensures you will all receive the latest edition. This report is updated annually and we will send you the latest edition once it has been published. By signing up for standing order you will never have to worry about the timeliness of the information you need. And, you may discontinue standing orders at any time by contacting us at 1.800.372.1033, option 5, or by sending us an email to email@example.com.
Put me on standing order
Notify me when new releases are available (no standing order will be created)